Evaxion A/S Files July 2025 6-K Report
Ticker: EVAX · Form: 6-K · Filed: Jul 17, 2025 · CIK: 1828253
| Field | Detail |
|---|---|
| Company | Evaxion A/S (EVAX) |
| Form Type | 6-K |
| Filed Date | Jul 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, registration-statement
TL;DR
Evaxion A/S filed a 6-K on 7/17/25, incorporating previous filings. Keep an eye on their ongoing disclosures.
AI Summary
Evaxion A/S filed a Form 6-K on July 17, 2025, to report information for the month of July 2025. This filing incorporates by reference previous registration statements on Forms S-8 and F-3, as well as multiple Form F-1 filings, indicating ongoing capital raising or reporting activities.
Why It Matters
This filing indicates ongoing reporting and potential capital-raising activities by Evaxion A/S, which could impact investors' understanding of the company's financial and regulatory status.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) that incorporates previous filings, not announcing new material events.
Key Numbers
- July 2025 — Reporting Period (This Form 6-K covers the month of July 2025.)
- 001-39950 — Commission File Number (Identifies Evaxion A/S's filing with the SEC.)
Key Players & Entities
- Evaxion A/S (company) — Registrant
- 001-39950 (dollar_amount) — Commission File Number
- 333-255064 (dollar_amount) — Form S-8 File Number
- 333-265132 (dollar_amount) — Form F-3 File Number
- 333-266050 (dollar_amount) — Form F-1 File Number
- 333-276505 (dollar_amount) — Form F-1 File Number
- 333-279153 (dollar_amount) — Form F-1 File Number
- 333-283304 (dollar_amount) — Form F-1 File Number
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a report of a foreign private issuer pursuant to Section 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of July 2025.
What other SEC filings are incorporated by reference into this report?
This report incorporates by reference Evaxion A/S's registration statements on Form S-8 (File No. 333-255064), Form F-3 (File No. 333-265132), and multiple Form F-1 filings (File Nos. 333-266050, 333-276505, 333-279153, 333-283304).
What is Evaxion A/S's principal executive office address?
Evaxion A/S's principal executive offices are located at Dr. Neergaards Vej 5f, DK-2970 Hoersholm, Denmark.
Does Evaxion A/S file annual reports under Form 20-F or Form 40-F?
The filing indicates that Evaxion A/S files annual reports under cover of Form 20-F.
What was Evaxion A/S's former company name?
Evaxion A/S's former company name was Evaxion Biotech A/S, with a date of name change on October 14, 2020.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 17, 2025 regarding Evaxion A/S (EVAX).